• BX795: Dissecting Kinase Signaling and Autophagy in Immunity

  2026-08-05

  Explore how BX795, a leading PDK1 inhibitor, uniquely enables researchers to probe the interplay between innate immune signaling, TBK1-mediated autophagy, and cancer cell growth. This article reveals new mechanistic insights, grounded in recent literature, and highlights distinct applications beyond traditional oncology assays.

• Probiotic LP.P101 Reduces Alcohol-Induced Liver Lipids via A

  2026-08-05

  This study reveals that Lactiplantibacillus plantarum P101 (LP.P101) mitigates alcohol-induced hepatic lipid accumulation in mice through activation of the AMPK pathway, with gut microbiota and serum metabolite changes contributing to the effect. The work uses the AMPK inhibitor Dorsomorphin to clarify mechanistic pathways, providing a robust model for metabolic research.

• Firefly Luciferase mRNA: Precision Reporter for Gene Express

  2026-08-04

  Firefly Luciferase mRNA (ARCA, 5mCTP, ΨUTP) delivers exceptional consistency and sensitivity for gene expression and cell viability assays through advanced mRNA engineering. Its optimized cap structure and modified nucleotides translate into superior stability and robust bioluminescent readouts, making it an indispensable control and reporter for both in vitro and in vivo workflows.

• hly Gene Deletion Impairs Biofilm and Antibiotic Resistance

  2026-08-04

  This study reveals that deletion of the hly gene in Listeria monocytogenes significantly disrupts biofilm formation and increases sensitivity to ribosome-targeting antibiotics. The findings highlight hly as a key regulator of biofilm integrity, motility, and virulence, suggesting new intervention targets for food safety and pathogen control.

• LDN-193189: Precision ALK Inhibition for Translational Impac

  2026-08-03

  Discover how LDN-193189, a selective BMP type I receptor inhibitor, is transforming translational research with mechanistic precision, robust validation, and workflow advantages. This article bridges advanced BMP pathway biology with actionable protocols, competitive positioning, and visionary outlooks for epithelial, stem cell, and neurodegenerative disease models.

• ECL Western Blotting Substrate: Practical Protocol & QC Use

  2026-08-03

  ECL Western Blotting Substrate (SKU K2187) provides a sensitive, nonradioactive solution for detecting horseradish peroxidase (HRP) in chemiluminescent Western blot assays. It is designed for protein detection workflows in molecular and cancer biology, but is not compatible with fluorescent or radioisotopic detection methods.

• N4-Acetylcytidine: Structural Insights and Experimental Desi

  2026-08-02

  Explore how N4-Acetylcytidine advances RNA epigenetics research, with a focus on the structural basis of its metabolism and practical guidance for experimental design. This article uniquely bridges molecular insight with real-world assay optimization.

• Reliable Cell Assays with A 83-01 (ALK inhibitor): Scenario

  2026-08-01

  This evidence-driven guide explores real laboratory challenges in cell viability, proliferation, and organoid modeling, demonstrating how A 83-01 (ALK inhibitor) (SKU A3133) delivers reproducible and sensitive results. Using scenario-based Q&A, we address protocol optimization, data interpretation, and product selection, referencing peer-reviewed benchmarks and validated best practices. Researchers will find actionable insights for leveraging A 83-01 (ALK inhibitor) in complex cellular systems.

• AZD3463 ALK/IGF1R Inhibitor: Applied Workflows & Advanced Ti

  2026-07-31

  AZD3463 stands out as a dual ALK/IGF1R inhibitor, enabling precise dissection of oncogenic signaling and resistance mechanisms in neuroblastoma and related cancer models. This guide delivers actionable protocols, troubleshooting strategies, and translational insights for maximizing research impact with APExBIO’s AZD-3463.

• Multianimal MRI Streamlines Pancreatic Tumor Monitoring in M

  2026-07-31

  Kempinska et al. introduce a multianimal MRI protocol that enables high-resolution, parallel imaging for efficient tumor measurement in KPC mouse models of pancreatic ductal adenocarcinoma. This approach accelerates preclinical evaluation of therapeutics, including gemcitabine, by reducing imaging time and cost while maintaining data precision.

• A 83-01: Strategic ALK-5 Inhibition for Translational Scienc

  2026-07-30

  This thought-leadership article explores the mechanistic foundation and translational promise of A 83-01 (ALK inhibitor) as a next-generation tool for dissecting TGF-β signaling, Smad-dependent transcription, and epithelial-mesenchymal transition (EMT). With a focus on bridging experimental rigor and workflow innovation, we contextualize A 83-01’s value in light of recent WNT pathway findings in cholangiopathies and highlight practical guidance for protocol optimization.

• Lamotrigine in Advanced BBB Models: Applied CNS Assay Workfl

  2026-07-30

  Lamotrigine, a 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine, is pivotal for high-fidelity blood-brain barrier (BBB) permeability studies and sodium channel modulation research. This guide details optimized experimental protocols, troubleshooting insights, and the integration of Lamotrigine in cutting-edge CNS and cardiac assays, leveraging the latest surrogate barrier models.

• SB 431542: Unlocking TGF-β Pathway Inhibition for Antitumor

  2026-07-29

  Discover how SB 431542, a potent ALK5 inhibitor, is reshaping TGF-β pathway research and antitumor immune modulation. This in-depth article explores advanced applications, mechanistic insights, and the latest breakthroughs in immuno-oncology assays.

• O-GlcNAcylation Directs Wnt-Driven Bone Formation via Glycol

  2026-07-29

  This study uncovers that O-GlcNAcylation is essential for Wnt-stimulated bone formation by rewiring aerobic glycolysis, specifically through stabilization of PDK1. These findings clarify a key metabolic mechanism underlying osteogenesis and suggest new intervention targets for bone diseases.

• AZD3463 ALK/IGF1R Inhibitor: Precision Tools for Neuroblasto

  2026-07-28

  AZD3463 stands out as a dual ALK/IGF1R inhibitor with proven efficacy against both wild-type and mutant ALK-driven neuroblastoma, facilitating apoptosis, autophagy, and enhanced chemosensitivity. This guide translates cutting-edge research into actionable workflows, practical troubleshooting, and protocol optimization for reliable experimental outcomes.

16066 records 1/1072 page Next 12345 下5页 Last page